UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 26, 2015

 

 

ADVANCED BIOENERGY, LLC

(Exact name of Registrant as Specified in Charter)

 

 

Delaware

(State or Other Jurisdiction

of Incorporation)

 

000-52421   20-2281511

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

8000 Norman Center Drive

Suite 610

Bloomington, MN

  55437
(Address of Principal Executive Offices)   (Zip Code)

763-226-2701

Registrant’s Telephone Number, Including Area Code

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

On March 26, 2015, the Company held its Regular Meeting of Members (the “Regular Meeting”). Of the Company’s 25,410,851 membership units outstanding and entitled to vote at the Regular Meeting, 18,643,172 membership units or 73.4% were present either in person or by proxy.

The following describes the matters considered by the Company’s members at the Regular Meeting, as well as the final results of the votes cast at the meeting.

 

1. To set at seven the number of directors to be elected for a term of one year or until their successors are elected and qualified.

 

For

 

Against

 

Abstain

18,367,897   102,482   117,927

 

2. To elect seven directors to serve for a period of one year or until their successors are elected and qualified.

 

Nominee

   For      Withhold  

Scott A. Brittenham

     17,874,393         484,141   

Daniel R. Kueter

     18,208,406         150,128   

Charles M. Miller

     18,186,133         172,401   

Joshua M. Nelson

     18,188,405         170,129   

Troy L. Otte

     18,215,206         143,328   

Richard R. Peterson

     18,192,905         165,629   

JD Schlieman

     18,185,105         173,429   

 

3. To ratify the appointment of McGladrey LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2015.

 

For

 

Against

 

Abstain

18,353,648   108,799   128,125

 

4. To cast a non-binding advisory vote approving executive compensation.

 

For

 

Against

 

Abstain

16,328,691   1,346,004   864,335

 


As a result, each nominee listed in Proposal 2 was elected as a director of the Company and Proposals 1, 3 and 4 were approved.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ADVANCED BIOENERGY, LLC
By:

/s/ Richard R. Peterson

Richard R. Peterson
President, Chief Executive Officer and Chief Financial Officer

Date: March 31, 2015